Improving access to care for people living with HIV and affected by TB
Niger is struggling to integrate all the components necessary for the continuous availability of laboratory services and to ensure the link with health care teams for access to better quality care for patients. This poor performance is due to shortcomings throughout the healthcare chain in relation to laboratories. In terms of HIV care, Niger is lagging far behind in achieving the UNAIDS targets of 90-90-90. As of December 2018, Niger had 35 300 people living with HIV (PLHIV), of whom 72% knew their status, 54% were receiving antiretroviral treatment and 45% had an undetectable viral load. By 2016, viral load coverage was 21%. There is also an under-utilization of viral load results in the management of patient treatment failure, with too little virological monitoring and changes in ARV treatment to 2nd line. The early diagnosis of HIV infection in children remains a challenge in the country, with coverage of diagnostic needs at 8%. With regard to tuberculosis, Niger is struggling to achieve the objectives of the WHO strategy for 2035, particularly with regard to reducing the number of deaths and reducing incidence.
|Duration: 3 years (2020-2023)
Area of intervention: Niger (Niamey, Dosso)
Source of funding: L’nitiative (Expertise France)
Beneficiaries: PNLSH (National Programme for the Fight against HIV/AIDS and Hepatitis), National TB/HIV Reference Laboratory, Health Laboratories Directorate, National Directorate of Pharmacy, PNLT (National Programme for the Fight against Tuberculosis)
Partners: Ministry of Public Health of Niger, The Niger Network of People Living with HIV (RENIP+), Fondation Mérieux
To contribute to improving access to quality care for people living with HIV (PLHIV) and people with tuberculosis (TB) in Niger.
The Labo 2S project aims to strengthen the quality and integration of HIV and tuberculosis services within laboratory services linked to the continuum of care. Activities will be carried out at the level of care centres, communities, laboratories and at the institutional level.
Expected Key Results :
- The capacity of health care teams and patient communities is strengthened to enable access to diagnostic and follow-up examinations for PLWHIV (including exposed infants) and/or TB patients and their use to adapt patient management.
- The capacity of technical facilities is strengthened to ensure the availability and quality of laboratory services for PLWHIV and/or people living with TB.
- National capacities are strengthened for the development of an integrated HIV and TB laboratory strategy within the health system.